mebendazole has been researched along with Leukemia in 2 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Spagnuolo, PA | 1 |
| Hu, J | 1 |
| Hurren, R | 1 |
| Wang, X | 1 |
| Gronda, M | 1 |
| Sukhai, MA | 1 |
| Di Meo, A | 1 |
| Boss, J | 1 |
| Ashali, I | 1 |
| Beheshti Zavareh, R | 1 |
| Fine, N | 1 |
| Simpson, CD | 1 |
| Sharmeen, S | 1 |
| Rottapel, R | 1 |
| Schimmer, AD | 1 |
| Delatour, P | 1 |
| Lorgue, G | 1 |
| Lapras, M | 1 |
| Richard, Y | 1 |
2 other studies available for mebendazole and Leukemia
| Article | Year |
|---|---|
The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma.
Topics: Animals; Antinematodal Agents; Antineoplastic Agents, Phytogenic; Cell Death; Cell Survival; Dose-Re | 2010 |
[Embryotoxic and antimitotic properties of parbendazole, mebendazole and cambendazole].
Topics: Abnormalities, Drug-Induced; Animals; Benzimidazoles; Cambendazole; Carcinoma, Ehrlich Tumor; Embryo | 1976 |